191 related articles for article (PubMed ID: 29428424)
1. Parvovirus B19 and in situ immune response in eczema and psoriasis skin lesions of patients from the Brazilian Amazon region.
Simões ACL; de Souza Aarão TL; de Sousa JR; Prudente DL; de Castro YG; Maneschy RB; Fuzii HT; Quaresma JAS
Microb Pathog; 2018 Apr; 117():27-31. PubMed ID: 29428424
[TBL] [Abstract][Full Text] [Related]
2. A high prevalence of parvovirus B19 DNA in patients with psoriasis.
Yazici AC; Aslan G; Baz K; Ikizoglu G; Api H; Serin MS; Tezcan S; Emekdas G; Tasdelen B
Arch Dermatol Res; 2006 Oct; 298(5):231-5. PubMed ID: 16862431
[TBL] [Abstract][Full Text] [Related]
3. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma.
Magro CM; Nuovo G; Ferri C; Crowson AN; Giuggioli D; Sebastiani M
J Cutan Pathol; 2004 Jan; 31(1):43-50. PubMed ID: 14675284
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
5. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
Kerr JR; Cunniffe VS; Kelleher P; Coats AJ; Mattey DL
J Med Virol; 2004 Sep; 74(1):147-55. PubMed ID: 15258981
[TBL] [Abstract][Full Text] [Related]
6. The prevalence and persistence of human parvovirus B19 infection in thalassemic patients.
Siritantikorn S; Kaewrawang S; Siritanaratkul N; Theamboonlers A; Poovorawan Y; Kantakamalakul W; Wasi C
Asian Pac J Allergy Immunol; 2007; 25(2-3):169-74. PubMed ID: 18035805
[TBL] [Abstract][Full Text] [Related]
7. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.
Nigro G; Bastianon V; Colloridi V; Ventriglia F; Gallo P; D'Amati G; Koch WC; Adler SP
Clin Infect Dis; 2000 Jul; 31(1):65-9. PubMed ID: 10913398
[TBL] [Abstract][Full Text] [Related]
8. [An exceptional cause of acute hepatitis in an adult: parvovirus B19].
Martínez González J; Senosiain Lalastra C; Mesonero Gismero F; Moreira Vicente V
Gastroenterol Hepatol; 2012 Dec; 35(10):697-9. PubMed ID: 22749503
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.
Naciute M; Mieliauskaite D; Rugiene R; Maciunaite G; Mauricas M; Murovska M; Girkontaite I
Cytokine; 2017 Aug; 96():41-48. PubMed ID: 28288327
[TBL] [Abstract][Full Text] [Related]
10. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus B19 is a bystander in adult myocarditis.
Koepsell SA; Anderson DR; Radio SJ
Cardiovasc Pathol; 2012; 21(6):476-81. PubMed ID: 22425629
[TBL] [Abstract][Full Text] [Related]
12. Detection of parvovirus B19 infection in first and second trimester fetal loss.
de Krijger RR; van Elsacker-Niele AM; Mulder-Stapel A; Salimans MM; Dreef E; Weiland HT; van Krieken JH; Vermeij-Keers C
Pediatr Pathol Lab Med; 1998; 18(1):23-34. PubMed ID: 9566279
[TBL] [Abstract][Full Text] [Related]
13. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
[TBL] [Abstract][Full Text] [Related]
15. Focal epilepsy as a long term sequela of Parvovirus B19 encephalitis.
Palermo CI; Costanzo CM; Franchina C; Castiglione G; Giuliano L; Russo R; Conti A; Sofia V; Scalia G
J Clin Virol; 2016 Jul; 80():20-3. PubMed ID: 27130981
[TBL] [Abstract][Full Text] [Related]
16. The cutaneous manifestations of human parvovirus B19 infection.
Magro CM; Dawood MR; Crowson AN
Hum Pathol; 2000 Apr; 31(4):488-97. PubMed ID: 10821497
[TBL] [Abstract][Full Text] [Related]
17. Human parvovirus B19 associated with idiopathic thrombocytopenic purpura.
Aktepe OC; Yetgin S; Olcay L; Ozbek N
Pediatr Hematol Oncol; 2004; 21(5):421-6. PubMed ID: 15205085
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
Heinz C; Plentz A; Bauer D; Heiligenhaus A; Modrow S
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):999-1004. PubMed ID: 15906067
[TBL] [Abstract][Full Text] [Related]
19. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens.
Pankuweit S; Moll R; Baandrup U; Portig I; Hufnagel G; Maisch B
Hum Pathol; 2003 May; 34(5):497-503. PubMed ID: 12792925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
